Innovative Spinal Technologies, Inc. (IST), a privately held medical technology company focused on developing the world's most advanced minimally invasive treatments for spinal disorders, announced today that it closed a $39 million Series B financing. The funding includes a team of investors led by OrbiMed Advisors, MPM Capital, and JPMorgan Partners. The financing will be used to expand IST's world-class team and to accelerate the launch of its next-generation spinal devices.

INFO SOURCES

Innovative Spinal Technologies, Inc.
Scott Schorer, 617-425-9280
info@istspine.com

FIRMS

Innovative Spinal Technologies, Inc. ("IST") was founded in 2002 as an incubator at the Texas Back Institute by Stephen Hochschuler, M.D., and Barton Sachs, M.D., M.B.A. Since then, IST has evolved into an integrated products company focused on addressing areas of minimally invasive spine surgery and motion preservation. IST's partners include some of the world's most advanced clinical leaders and an investor team of the highest quality.

LINKED TO

OrbiMed Advisors, MPM Capital, and JPMorgan Partners

BOARD/MANAGEMENT

Rob Adelman, M.D., of OrbiMed Advisors, Luke Evnin, Ph.D., of MPM Capital and John Ryan of JPMorgan Partners will join IST's Board.